[Recent progress in the treatment of Cushing's disease]

Ann Endocrinol (Paris). 2012 Apr;73(2):107-10. doi: 10.1016/j.ando.2012.03.036. Epub 2012 Apr 24.
[Article in French]

Abstract

Transsphenoidal surgery, possibly through the endoscopic approach, remains the first line treatment. Opposing cortisol action with mifepristone proved efficacious in some individual cases but but with major monitoring difficulties. Combined treatment with three anticortisolic drugs (metyrapone, ketokonazole, O,p'DDD) is particularly attractive in severe cases. The Nelson's syndrome has been revisited, and the corticotroph tumor progression should rather be cautiously assessed after bilateral adrenalectomy. Two molecules potentially act directly to suppress the ACTH secretion by the corticotroph adenoma: agonists of the D2 Dopamine receptor and of the somatostatin receptor type 5. Their efficacy remains modest (20 to 30% of the patients actually normalize urinary cortisol). Pituitary radiotherapy can be efficiently performed by stereotaxic approach.

Publication types

  • Review

MeSH terms

  • ACTH-Secreting Pituitary Adenoma / complications
  • ACTH-Secreting Pituitary Adenoma / surgery
  • Adenoma / complications
  • Adenoma / surgery
  • Endocrinology / methods*
  • Endocrinology / trends*
  • Hormone Antagonists / therapeutic use
  • Humans
  • Hydrocortisone / antagonists & inhibitors
  • Models, Biological
  • Neurosurgical Procedures / methods
  • Neurosurgical Procedures / statistics & numerical data
  • Pituitary ACTH Hypersecretion / complications
  • Pituitary ACTH Hypersecretion / therapy*
  • Radiotherapy / statistics & numerical data

Substances

  • Hormone Antagonists
  • Hydrocortisone